Résultats de la recherche - 9 results
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; Lan Xu Source: Expert Rev Vaccines, Volume 17, Issue 12 (2018) Keywords: Cervical cancer; HPV vaccines; meta-analysis; ...
Triage of HPV positive women in cervical cancer screening.
Papillomavirus Infections Risk Factors triage Uterine Cervical Neoplasms Abstract: Despite HPV vaccines, screening will remain central for decades to control cervical cancer. Recently, HPV testing alone or with ...
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
Trottier, Helen Source: Lancet Oncol, Volume 15, Issue 12, p.1319-31 (2014) Keywords: Carcinogenesis Cyclin-Dependent Kinase Inhibitor p16 DNA, Viral Head and Neck Neoplasms Human papillomavirus 16 Humans ...
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
Trottier, Helen Source: The Lancet Oncology, Volume 15, Issue 12 (2014) Keywords: HPV DNA meta-analyses neck cancer Abstract: BACKGROUND We aimed to provide updated information about the global estimates of ...
HPV testing and vaccination in Europe.
Papillomavirus DNA Tests Humans Papillomaviridae Papillomavirus Infections Papillomavirus Vaccines Uterine Cervical Neoplasms Vaccination Abstract: Current cytology-based screening has a moderate sensitivity to ...
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
Source: Vaccine, Volume 31 Suppl 7, p.H59-70 (2013) Keywords: Early Detection of Cancer Europe, Eastern Female Genotype Humans Papillomaviridae Papillomavirus Infections Papillomavirus Vaccines prevalence ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
antibodies against the vaccine HPV types). We will assess clinical effectiveness by evaluating outcomes in all women, irrespective of the HPV DNA or serology status at enrolment. Evaluation by fine age and ...
Cervical cytology biobanking in Europe.
Dillner, Joakim Source: Int J Biol Markers, Volume 25, Issue 3, p.117-25 (2010) Keywords: Alphapapillomavirus Biological Specimen Banks Cervix Uteri Dna Europe Female Guidelines as Topic Humans Medical ...
HPV-FASTER: broadening the scope for prevention of HPV-related cancer.
restricted indications for HPV vaccination. Trials of HPV vaccination in women aged up to 55 years have shown almost 90% protection from cervical precancer caused by HPV16 /18 among HPV16 /18- DNA ...